Background and Objectives
drug-resistant epilepsy, Epilepsy, Thalamus
ANTERIOR, EPILEPSY, APPENDIX
Go to The Article Processing Charge was funded by Medtronic.The MORE Study Group coinvestigators are listed in Appendix 2 at Submitted and externally peer reviewed. The handling editor was Associate Editor Barbara Jobst, MD, PhD, FAAN.The efficacy of deep brain stimulation of the anterior nucleus of the thalamus (ANT DBS) in patients with drug-resistant epilepsy (DRE) was demonstrated in the double-blind Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy randomized controlled trial. The Medtronic Registry for Epilepsy (MORE) aims to understand the safety and longer-term effectiveness of ANT DBS therapy in routine clinical practice.